A case of membranous nephropathy following Pfizer-BioNTech mRNA vaccination against COVID-19

Kidney Int. 2021 Oct;100(4):938-939. doi: 10.1016/j.kint.2021.07.016. Epub 2021 Jul 30.

Authors

Yi Da¹, Giap Hean Goh², Priyanka Khatri³

Affiliations

¹ Division of Nephrology, Department of Medicine, National University Hospital, Singapore. Electronic address: yi_da@nuhs.edu.sg.
² Department of Pathology, National University Hospital, Singapore.
³ Division of Nephrology, Department of Medicine, National University Hospital, Singapore; FAST and Chronic Programmes, Alexandra Hospital, Singapore.

No abstract available

Publication types

Letter
Comment

MeSH terms

COVID-19*
Glomerulonephritis, Membranous* / drug therapy
Humans
RNA, Messenger
SARS-CoV-2
Vaccination

Substances

RNA, Messenger